Related references
Note: Only part of the references are listed.Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability
Marika Massaro et al.
CARDIOVASCULAR RESEARCH (2010)
Nuclear receptor Nur77 suppresses inflammatory response dependent on COX-2 in macrophages induced by oxLDL
Qin Shao et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Early morphological changes of an Amplatzer Septal Occluder explanted at heart transplant
Eric Ahn et al.
CARDIOVASCULAR PATHOLOGY (2009)
A chemoenzymatic approach to the synthesis of enantiomerically pure (S)-3-hydroxy-γ-butyrolactone
Sang-Hyun Lee et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2008)
Oxidized low-density lipoprotein induces differentiation of RAW264.7 murine macrophage cell line into dendritic-like cells
Ling-Hon Shen et al.
ATHEROSCLEROSIS (2008)
Oxidized low density lipoprotein activates peroxisome proliferator-activated receptor-α(PPARα) and PPARγ through MAPK-dependent COX-2 expression in macrophages
Kayo Taketa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Simvastatin suppresses LPS-induced MMP-1 expression in U937 mononuclear cells by inhibiting protein isoprenylation-mediated ERK activation
Kamala P. Sundararaj et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Rosuvastatin regulates vascular smooth muscle cell phenotypic modulation in vascular remodeling:: Role for the urokinase receptor
Julia Kiyan et al.
ATHEROSCLEROSIS (2007)
Rosuvastatin suppresses the inflammatory responses through inhibition of c-jun N-terminal kinase and nuclear factor-κB in endothelial cells
Yong Sook Kim et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
Modulation of COX-2 expression by statins in human monocytic cells
Aida Habib et al.
FASEB JOURNAL (2007)
High glucose-boosted inflammatory responses to lipopolysaccharide are suppressed by statin
A. Nareika et al.
JOURNAL OF PERIODONTAL RESEARCH (2007)
Lovastatin-induced apoptosis in macrophages through the Rac1/Cdc42/JNK pathway
Shu-Ling Liang et al.
JOURNAL OF IMMUNOLOGY (2006)
Signalling networks regulating cyclooxygenase-2
Christos Tsatsanis et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2006)
Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition beyond low-density lipoprotein cholesterol
JK Liao
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Cyclooxygenase-2 promotes early atherosclerotic lesion formation in apoE-deficient and C57BL/6 mice
ME Burleigh et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)
Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease
GK Hansson
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Chemokines - Key regulators of mononuclear cell recruitment in atherosclerotic vascular disease
C Weber et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Lack of interleukin-1β decreases the severity of atherosclerosis in ApoE-deficient mice
H Kirii et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice
ME Burleigh et al.
CIRCULATION (2002)
Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells
MA Hernandez-Presa et al.
ATHEROSCLEROSIS (2002)
Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors
M Takemoto et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
LPS induction of gene expression in human monocytes
M Guha et al.
CELLULAR SIGNALLING (2001)
Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability
KK Koh
CARDIOVASCULAR RESEARCH (2000)
Selective inhibition of NF-kappa B activation by a peptide that blocks the interaction of NEMO with the I kappa B kinase complex
MJ May et al.
SCIENCE (2000)
Share Paper
